Cellectar Biosciences (CLRB) Q2 2024 Earnings

14MayConfirmed
Q2 2023
Q3 2023
Q4 2023
Q2 2024
-0.82
-0.68
-0.54
-0.4

Details

Expected EPS
-0.493333
Actual EPS
-0.74
Surprise EPS
-0.25
Surprise Percent
+50%

Description

Cellectar Biosciences (CLRB) has reported earnings of -0.74 per share for Q2 2024.

0 Comments

Share your thoughts